Home » Authors » Tom Rusk, M.D.

Tom Rusk, M.D.

is Chief of Adult Psychiatry at Community Health & Counseling Services in Winterport, Maine. He shares his approach to minimizing the risk of SSRI-induced agitation.

Articles

ARTICLES

Anecdotes From The Field

January 1, 2005

Tom Rusk, M.D.

Tom Rusk, M.D. is Chief of Adult Psychiatry at Community Health & Counseling Services in Winterport, Maine. He shares his approach to minimizing the risk of SSRI-induced agitation. Dr. Rusk has disclosed that he is a member of the speakers bureau of Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Astra Zeneca, and Eli Lilly.

Eight or nine years ago I had a couple of young adults become highly agitated and violent in the week after I started an SSRI (paroxetine in both cases). One beat up his girlfriend badly despite the lack of any history of violence previously.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Treating Opioid Use Disorder—A Fact Book (2024)
All the tools you need to assess and treat patients struggling with opioid use disorder.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: What Patients Won’t Tell You
How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.
Listen now